OTCPK:GBOK.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Greenbrook TMS Inc., together with its subsidiaries, operates a network of outpatient mental health services centers in the United States. More Details


Snowflake Analysis

Adequate balance sheet and slightly overvalued.

Share Price & News

How has Greenbrook TMS's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GBOK.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

GBOK.F

-3.6%

US Healthcare

-1.9%

US Market


1 Year Return

-39.6%

GBOK.F

15.9%

US Healthcare

13.1%

US Market

Return vs Industry: GBOK.F underperformed the US Healthcare industry which returned 16.7% over the past year.

Return vs Market: GBOK.F underperformed the US Market which returned 12.7% over the past year.


Shareholder returns

GBOK.FIndustryMarket
7 Day0%-3.6%-1.9%
30 Day-1.9%-5.7%-2.9%
90 Day-2.8%-1.9%8.2%
1 Year-39.6%-39.6%17.4%15.9%15.7%13.1%
3 Yearn/a23.1%17.7%38.4%29.1%
5 Yearn/a51.0%40.3%89.3%68.0%

Price Volatility Vs. Market

How volatile is Greenbrook TMS's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Greenbrook TMS undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GBOK.F ($1.05) is trading below our estimate of fair value ($8.82)

Significantly Below Fair Value: GBOK.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GBOK.F is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: GBOK.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GBOK.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GBOK.F is overvalued based on its PB Ratio (3.7x) compared to the US Healthcare industry average (2.8x).


Next Steps

Future Growth

How is Greenbrook TMS forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

43.9%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if GBOK.F's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if GBOK.F's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GBOK.F's revenue (43.9% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: GBOK.F's revenue (43.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if GBOK.F's Return on Equity is forecast to be high in 3 years time


Next Steps

  • Explore growth companies in the Healthcare industry.

Past Performance

How has Greenbrook TMS performed over the past 5 years?

-53.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GBOK.F is currently unprofitable.

Growing Profit Margin: GBOK.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: GBOK.F is unprofitable, and losses have increased over the past 5 years at a rate of 53.1% per year.

Accelerating Growth: Unable to compare GBOK.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GBOK.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: GBOK.F has a negative Return on Equity (-126.35%), as it is currently unprofitable.


Next Steps

Financial Health

How is Greenbrook TMS's financial position?


Financial Position Analysis

Short Term Liabilities: GBOK.F's short term assets ($26.5M) exceed its short term liabilities ($21.3M).

Long Term Liabilities: GBOK.F's short term assets ($26.5M) exceed its long term liabilities ($24.9M).


Debt to Equity History and Analysis

Debt Level: GBOK.F's debt to equity ratio (15.7%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if GBOK.F's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: GBOK.F has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if GBOK.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Greenbrook TMS current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate GBOK.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GBOK.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GBOK.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GBOK.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GBOK.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure


CEO

Bill Leonard (55 yo)

9.67yrs

Tenure

US$500,000

Compensation

Mr. Bill Leonard serves as President and Chief Executive Officer of Greenbrook TMS Inc since 2011 and also serves as its Director since February 2018. Mr. Leonard is the President and Chief Executive Offic ...


CEO Compensation Analysis

Compensation vs Market: Bill's total compensation ($USD500.00K) is about average for companies of similar size in the US market ($USD601.89K).

Compensation vs Earnings: Bill's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Bill Leonard
President9.67yrsUS$500.00k6.17%
$ 4.3m
Erns Loubser
CFO, Treasurer & Corporate Secretary2.58yrsUS$375.00kno data
Roberto Drassinower
Chief Operating Officer2.58yrsUS$307.50kno data
Euphia Smith
Chief Marketing Officer1.33yrsUS$372.60kno data
Geoffrey Grammer
Chief Medical Officer3.67yrsUS$232.40kno data
Glen Akselrod
Investor Relations Officerno datano datano data

2.6yrs

Average Tenure

Experienced Management: GBOK.F's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bill Leonard
President9.67yrsUS$500.00k6.17%
$ 4.3m
Adele Oliva
Independent Director1.25yrsUS$12.50kno data
Frank Tworecke
Independent Director1.92yrsUS$25.00k0.30%
$ 208.9k
Elias Vamvakas
Chairman2.58yrsUS$50.00kno data
Adrienne Graves
Independent Director1.92yrsUS$25.00kno data
Colleen Campbell
Lead Independent Directorno dataUS$30.00k0.037%
$ 26.1k
Brian Burke
Independent Director1.92yrsUS$30.00kno data
Sasha Cucuz
Director2yrsUS$25.00kno data

1.9yrs

Average Tenure

61.5yo

Average Age

Experienced Board: GBOK.F's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.5%.


Top Shareholders

Company Information

Greenbrook TMS Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Greenbrook TMS Inc.
  • Ticker: GBOK.F
  • Exchange: OTCPK
  • Founded: 2011
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$93.842m
  • Listing Market Cap: CA$70.516m
  • Shares outstanding: 67.51m
  • Website: https://www.greenbrooktms.com

Number of Employees


Location

  • Greenbrook TMS Inc.
  • 890 Yonge Street
  • 7th Floor
  • Toronto
  • Ontario
  • M4W 3P4
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GTMSTSX (The Toronto Stock Exchange)YesCommon SharesCACADOct 2018
GBOK.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDOct 2018

Biography

Greenbrook TMS Inc., together with its subsidiaries, operates a network of outpatient mental health services centers in the United States. It offers transcranial magnetic stimulation therapy, an FDA-cleare ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/23 06:20
End of Day Share Price2020/09/18 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.